Hao Zhang,Lipeng Wang,Jin Cui,Sicheng Wang,Yafei Han,Hongda Shao,Cheng Wang,Yan Hu,Xiaoqun Li,Qirong Zhou,Jiawei Guo,Xinchen Zhuang,Shihao Sheng,Tao Zhang,Dongyang Zhou,Jiao Chen,Fuxiao Wang,Qianmin Gao,Yingying Jing,Xiao Chen,Jiacan Su

Abstract:Abnormal subchondral bone remodeling featured by overactivated osteoclastogenesis leads to articular cartilage degeneration and osteoarthritis (OA) progression, but the mechanism is unclear. We used lymphocyte cytosolic protein 1 ( Lcp1 ) knockout mice to suppress subchondral osteoclasts in a mice OA model with anterior cruciate ligament transection (ACLT), and Lcp1 −/− mice showed decreased bone remodeling in subchondral bone and retarded cartilage degeneration. For mechanisms, the activated osteoclasts in subchondral bone induced type-H vessels and elevated oxygen concentration, which ubiquitylated hypoxia-inducible factor 1 alpha subunit (HIF-1α) in chondrocytes and led to cartilage degeneration. Lcp1 knockout impeded angiogenesis, which maintained hypoxia environment in joints and delayed the OA progression. Stabilization of HIF-1α delayed cartilage degeneration, and knockdown of Hif1a abolished the protective effects of Lcp1 knockout. Last, we showed that Oroxylin A, an Lcp1- encoded protein l -plastin (LPL) inhibitor, could alleviate OA progression. In conclusion, maintaining hypoxic environment is an attractive strategy for OA treatment.

Maintaining hypoxia environment of subchondral bone alleviates osteoarthritis progression